Furthermore, dysregulation of p16, CDK6, and pRB protein have all been associated with recurrence in atypical meningiomas (16) and homozygous deletions of the CDKN2A/B gene has also been associated with early meningioma recurrence (17). This evidence concerns the gene RB1 and meningioma.